RQA Member: USD ($) 0.00
Non-Member: USD ($) 57.00
Your Price: USD ($) 57.00
This webcast will provide the audience with relevant and current information on the requirements for safety reporting in clinical trials.
The focus is on the Clinical Trials Directive 2001/20/EC CT3 Detailed guidance on the collection, verification and presentation of adverse reaction reports arising from clinical trials on medicinal products for human use.
People from Clinical Development, Regulatory Affairs, Pharmacovigilance and Quality Assurance will benefit from this webcast.